Atenor’s €181.6 Million Capital Increase

Clifford Chance acted for the Joint Global Coordinators and Joint Bookrunners on the deal. Atenor, a leading real estate development company, completed a €181.6 million capital increase....

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Azelis’ €200 Million Capital Increase

Clifford Chance advised Azelis. Azelis, a leading global innovation service provider in the specialty chemicals and food ingredients industry listed on the regulated market of Euronext...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Nicox’s €10 Million Capital Increase

Clifford Chance advised Nicox on the deal. Nicox, an international company specializing in ophthalmology, raised funds by private placement of 6,849,316 new shares, each accompanied by...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Nicox’ €15 Million Private Placement

Clifford Chance advised Nicox on the deal. Nicox, an international ophthalmology company, completed a financing through a private placement of 6,000,000 new shares with warrants attached...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here